ARTV
Artiva Biotherapeutics, Inc.
6.80$
-2.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -40.3% | -454.3% | -6,010.4% | – | – | – | – | – | – | – | – | – | – | |
| 2.1% | 25.3% | 233.9% | – | – | – | – | – | – | – | – | – | – | |
| 5.1% | 59.2% | 560.2% | – | – | – | – | – | – | – | – | – | – | |
| -89.3% | -46.3% | -1,201.6% | – | – | – | – | – | – | – | – | – | – | |
| 0.7% | 27.1% | 7.2% | – | – | – | – | – | – | – | – | – | – | |
| -1.8% | -113.5% | 3,897.2% | – | – | – | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 87.9% | 40.9% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 45.7% | -526.9% | -2,113.1% | – | – | – | – | – | – | – | – | – | – | |
| -41.0% | -481.3% | -6,017.5% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.